关于先锋
Company Profile
Good news! Schubert ® Fenofibrate capsule is launched
Release time:
2020-09-02
good news! Shubeite® Fenofibrate Capsules Launched Fenofibrate Capsules belong to the third generation of fibrate lipid-lowering drugs, and are mainly used clinically to treat elevated triglyceride (TG), elevated very low-density lipoprotein (VLD), low-density lipoprotein cholesterol (LDL- C) Dyslipidemia characterized by elevated and decreased high-density lipoprotein (HDL). By activating peroxisome proliferator-activated receptor α to play a protective role in blood vessels, it can significantly reduce the risk of microvascular complications in patients with hyperlipidemia, metabolic syndrome, and type 2 diabetes. Micronized technology, uniform release, regular absorption, greatly improved bioavailability and curative effect.
good news! Shubeite® Fenofibrate Capsules Launched
Fenofibrate Capsules belong to the third generation of fibrate lipid-lowering drugs, and are mainly used clinically to treat elevated triglyceride (TG), elevated very low-density lipoprotein (VLD), low-density lipoprotein cholesterol (LDL- C) Dyslipidemia characterized by elevated and decreased high-density lipoprotein (HDL). By activating peroxisome proliferator-activated receptor α to play a protective role in blood vessels, it can significantly reduce the risk of microvascular complications in patients with hyperlipidemia, metabolic syndrome, and type 2 diabetes.
Micronized technology, uniform release, regular absorption, greatly improved bioavailability and curative effect.
Since its establishment in 2004, Anhui Pioneer Pharmaceutical Co., Ltd. has been an innovative pharmaceutical enterprise integrating R&D, production and sales with innovative drug R&D as its core and clinical needs as its orientation. industry pioneer.
In the future, the company will still adhere to the mission of benefiting mankind and committing to the continuous innovation of Chinese people's health, adhere to principles, and highlight new features. While continuously promoting the sales performance of products already on the market, speed up the pace of R&D and listing of products under research, enrich the R&D echelon, optimize the company's product structure, and ensure the company's sustainable development.
Related news
Contact us
Add：No.35 HongFeng Road, Hefei, Anhui, China.
Tel：86-551-65355028
Fax：86-551-65355022
Email：xfcn@xfcn.com
Follow us
Copyright © 2023 Anhui Pioneer Pharmaceutical Co., Ltd 皖ICP备2020016893号 Powered by：www.300.cn SEO
86-551-65355028